Why is Boston Bio falling/rising?

As of 22-Sep, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.65, which reflects a decrease of 0.17 or 2.17%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total return of -8.38% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also shown a significant drop in investor participation, with delivery volume plummeting by 93.94% against the 5-day average. There is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, Boston Bio's performance over the past week shows a decline of 4.97%, while the benchmark Sensex has increased by 0.46%. This stark contrast highlights the stock's underperformance relative to the market. Over the past month, Boston Bio has decreased by 3.89%, while the Sensex has gained 1.05%, further emphasizing the stock's struggles in comparison to the broader market trends. The medical equipment sector, in which Boston Bio operates, has also faced a downturn, falling by 2.85%, contributing to the overall negative sentiment surrounding the stock.